Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Biodesix Inc (BDSX)

Biodesix Inc (BDSX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 240,994
  • Shares Outstanding, K 145,177
  • Annual Sales, $ 49,090 K
  • Annual Income, $ -52,150 K
  • EBIT $ -33 M
  • EBITDA $ -22 M
  • 60-Month Beta 1.22
  • Price/Sales 4.88
  • Price/Cash Flow N/A
  • Price/Book 6.61

Options Overview Details

View History
  • Implied Volatility 317.22% ( +29.53%)
  • Historical Volatility 51.36%
  • IV Percentile 78%
  • IV Rank 29.24%
  • IV High 966.60% on 01/23/24
  • IV Low 48.89% on 08/15/24
  • Put/Call Vol Ratio 0.00
  • Today's Volume 1
  • Volume Avg (30-Day) 7
  • Put/Call OI Ratio 0.87
  • Today's Open Interest 221
  • Open Int (30-Day) 289

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/24
See More
  • Average Estimate -0.08
  • Number of Estimates 1
  • High Estimate -0.08
  • Low Estimate -0.08
  • Prior Year -0.12
  • Growth Rate Est. (year over year) +33.33%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.5500 +9.68%
on 10/22/24
1.8000 -5.56%
on 10/01/24
-0.0800 (-4.49%)
since 09/30/24
3-Month
1.4714 +15.54%
on 08/13/24
2.0400 -16.67%
on 08/30/24
+0.0100 (+0.59%)
since 07/30/24
52-Week
1.1500 +47.83%
on 04/10/24
2.2100 -23.08%
on 02/05/24
+0.2200 (+14.86%)
since 10/30/23

Most Recent Stories

More News
Biodesix to Participate in Three Investor Conferences in November

BDSX : 1.7000 (+2.41%)
Why Shares of CareDx Are Jumping Friday

The company's diagnostic tests may obtain better coverage from the Centers for Medicare & Medicaid Services.

BDSX : 1.7000 (+2.41%)
CDNA : 22.13 (-3.70%)
Biodesix to Report First Quarter 2023 Financial Results on May 11, 2023

Biodesix, Inc. (Nasdaq: BDSX), a leading data-driven diagnostic solutions company with a focus on lung disease, announced today that it will release financial results for first quarter ended March 31,...

BDSX : 1.7000 (+2.41%)
Biodesix Announces Fourth Quarter and Fiscal Year End 2022 Results and Highlights

Biodesix, Inc. (Nasdaq: BDSX), a leading data-driven diagnostic solutions company with a focus in lung disease, today announced its financial and operating results for the fourth quarter and year ended...

BDSX : 1.7000 (+2.41%)
Biodesix to Participate at Cowen’s 43rd Annual Healthcare Conference

Biodesix, Inc. (Nasdaq: BDSX), a leading data-driven diagnostic solutions company with a focus in lung disease, announced today that Scott Hutton, Chief Executive Officer of Biodesix, will participate...

BDSX : 1.7000 (+2.41%)
Biodesix to Report Fourth Quarter and Full Year 2022 Financial Results on March 6, 2023

Biodesix, Inc. (Nasdaq: BDSX), a leading data-driven diagnostic solutions company with a focus on lung disease, announced today that it will release financial results for the fourth quarter and year ended...

BDSX : 1.7000 (+2.41%)
Biodesix Announces First Four Private Payer Coverage Policies for the Nodify XL2® Test

Biodesix, Inc. (Nasdaq: BDSX), a leading data-driven diagnostic solutions company with a focus in lung disease, today announced positive coverage decisions from four private payers including Blue Cross...

BDSX : 1.7000 (+2.41%)
Biodesix Announces Appointment of Lawrence (Lair) T. Kennedy, Jr. to Board of Directors

Biodesix, Inc. (Nasdaq: BDSX), a leading data-driven diagnostic solutions company with a focus in lung disease, today announced the appointment of Lawrence (Lair) T. Kennedy, Jr. to the Company’s Board...

BDSX : 1.7000 (+2.41%)
Biodesix Ranked Top Proteomics Solutions Company by Life Sciences Review Magazine

Biodesix, Inc . (Nasdaq: BDSX), a leading data-driven diagnostic solutions company with a focus in lung disease, announced today that the Company was named the leading Proteomics Solutions Company in the...

BDSX : 1.7000 (+2.41%)
Biodesix Announces Closing of Upsized Public Offering and Full Exercise of Option to Purchase Additional Shares

Biodesix, Inc. (Nasdaq: BDSX), a leading data-driven diagnostic solutions company with a focus in lung disease, today announced the closing of its underwritten public offering of 35,075,000 shares of...

BDSX : 1.7000 (+2.41%)

Business Summary

Biodesix Inc. is a data-driven diagnostic solutions company. It offers blood-based tests across the lung cancer continuum of care. The company also offers include diagnostic research, clinical research, development, and testing services to biopharmaceutical companies, as well as develops and commercializes...

See More

Key Turning Points

3rd Resistance Point 1.8528
2nd Resistance Point 1.7863
1st Resistance Point 1.7431
Last Price 1.7000
1st Support Level 1.6334
2nd Support Level 1.5669
3rd Support Level 1.5237

See More

52-Week High 2.2100
Fibonacci 61.8% 1.8051
Last Price 1.7000
Fibonacci 50% 1.6800
Fibonacci 38.2% 1.5549
52-Week Low 1.1500

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar